The latest immunotherapy news and developments
Two new studies in Science and Science Immunology spotlight a group of intestinal T cells with α4β7 integrin receptors…
Researchers from Edith Cowan University (ECU) are leading ground-breaking global trials which could save lives…
Immunotherapy works by sparking the body’s own immune system into action against tumours. It has…
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Cyteph, a spin-out biotechnology company from QIMR Berghofer Medical Research Institute, has been awarded a…
A study led by researchers at the UCLA Jonsson Comprehensive Cancer Center suggests that IL-21, a soluble…
An AI-driven drug discovery company has announced a potentially best-in-class preclinical candidate targeting ENPP1 for cancer immunotherapy…
Justin Stebbing, Anglia Ruskin University Pancreatic cancer is one of the deadliest types of cancer.…
Researchers at University of Galway, Ireland, studying cell interactions in bowel cancer have identified innovative…
Triple-negative breast cancer (TNBC) is the most aggressive and deadly form of breast cancer with…